BioLineRx (BLRX) Tops Q3 EPS by 20c
BioLineRx (NASDAQ: BLRX) reported Q3 EPS of ($0.01), $0.20 better than the analyst estimate of ($0.21).
For earnings history and earnings-related data on BioLineRx (BLRX) click here.
BioLineRx (NASDAQ: BLRX) reported Q3 EPS of ($0.01), $0.20 better than the analyst estimate of ($0.21).
For earnings history and earnings-related data on BioLineRx (BLRX) click here.